Society for Immunotherapy of Cancer Publishes First Clinical Immunotherapy Treatment Guidelines for Squamous Cell Carcinoma of the Head and Neck
July 18, 2019
July 18, 2019
MILWAUKEE, Wisconsin, July 18 -- The Society for Immunotherapy of Cancer issued the following news release:
The Society for Immunotherapy of Cancer (SITC) has published the first clinical immunotherapy treatment guidelines for squamous cell carcinoma of the head and neck (HNSCC), providing oncologists and other advanced practice providers a clinical roadmap to treating this disease with immunotherapies approved in the United States.
"The Society for Immunotherapy o . . .
The Society for Immunotherapy of Cancer (SITC) has published the first clinical immunotherapy treatment guidelines for squamous cell carcinoma of the head and neck (HNSCC), providing oncologists and other advanced practice providers a clinical roadmap to treating this disease with immunotherapies approved in the United States.
"The Society for Immunotherapy o . . .